» Articles » PMID: 23585551

De-repression of FOXO3a Death Axis by MicroRNA-132 and -212 Causes Neuronal Apoptosis in Alzheimer's Disease

Overview
Journal Hum Mol Genet
Date 2013 Apr 16
PMID 23585551
Citations 151
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is a multifactorial and fatal neurodegenerative disorder for which the mechanisms leading to profound neuronal loss are incompletely recognized. MicroRNAs (miRNAs) are recently discovered small regulatory RNA molecules that repress gene expression and are increasingly acknowledged as prime regulators involved in human brain pathologies. Here we identified two homologous miRNAs, miR-132 and miR-212, downregulated in temporal cortical areas and CA1 hippocampal neurons of human AD brains. Sequence-specific inhibition of miR-132 and miR-212 induces apoptosis in cultured primary neurons, whereas their overexpression is neuroprotective against oxidative stress. Using primary neurons and PC12 cells, we demonstrate that miR-132/212 controls cell survival by direct regulation of PTEN, FOXO3a and P300, which are all key elements of AKT signaling pathway. Silencing of these three target genes by RNAi abrogates apoptosis caused by the miR-132/212 inhibition. We further demonstrate that mRNA and protein levels of PTEN, FOXO3a, P300 and most of the direct pro-apoptotic transcriptional targets of FOXO3a are significantly elevated in human AD brains. These results indicate that the miR-132/miR-212/PTEN/FOXO3a signaling pathway contributes to AD neurodegeneration.

Citing Articles

Good things come in small packages: The discovery of small RNAs in the smallest animal model.

Ma C, Lo S, Chin-Ming Tan B Biomed J. 2025; 48(1):100832.

PMID: 39952406 PMC: 11893309. DOI: 10.1016/j.bj.2025.100832.


Circ-ITCH inhibits bladder cancer progression through miR-184/FOXO3 axis.

Yang F, Guo Z, Wu J, Lu X Am J Transl Res. 2025; 16(12):7911-7923.

PMID: 39822512 PMC: 11733359. DOI: 10.62347/XBRV7186.


The neuroinflammatory role of microRNAs in Alzheimer's disease: pathological insights to therapeutic potential.

Liu W, Rao X, Sun W, Chen X, Yu L, Zhang J Mol Cell Biochem. 2024; .

PMID: 39567427 DOI: 10.1007/s11010-024-05164-0.


Exploring Therapeutic Strategies: The Relationship between Metabolic Disorders and FOXO Signalling in Alzheimer's Disease.

Kaur P, Khan H, Grewal A, Dua K, Singh S, Gupta G CNS Neurol Disord Drug Targets. 2024; 24(3):196-207.

PMID: 39473249 DOI: 10.2174/0118715273321002240919102841.


NACC2, a molecular effector of miR-132 regulation at the interface between adult neurogenesis and Alzheimer's disease.

Penning A, Snoeck S, Garritsen O, Tosoni G, Hof A, de Boer F Sci Rep. 2024; 14(1):21163.

PMID: 39256511 PMC: 11387632. DOI: 10.1038/s41598-024-72096-6.